David W. Goodman
Chairman at Pharmascience, Inc.
David W. Goodman active positions
Companies | Position | Start | End |
---|---|---|---|
Pharmascience, Inc.
Pharmascience, Inc. Pharmaceuticals: MajorHealth Technology Pharmascience, Inc. manufactures and distributes generic and drug products. It offers liquids, tablets, capsules, suppositories, powders, and ophthalmic. The company was founded by Morris Goodman and Ted S. Wise in 1983 and is headquartered in Montr?al, Canada. | Chairman | 2023-01-02 | - |
Chief Executive Officer | - | 2023-01-02 | |
President | - | 2023-01-02 | |
Bionpharma, Inc.
Bionpharma, Inc. Pharmaceuticals: MajorHealth Technology Bionpharma, Inc. provides various specialty pharmaceuticals. It offers Rx generic ANDA and OTC products. The company was founded on Noveber 1, 2014 and is headquartered in Princeton, NJ. | Director/Board Member | - | - |
Centraide of Greater Montreal
Centraide of Greater Montreal Miscellaneous Commercial ServicesCommercial Services Centraide of Greater Montreal supports community agencies in the neighbourhoods. It has four areas of action: supporting youth, providing basic needs, helping the socially isolated and bringing communities together. The company was founded in 1966 and is headquartered in Montr?al, Canada. | Director/Board Member | - | - |
10379085 Canada, Inc.
10379085 Canada, Inc. Financial ConglomeratesFinance 10379085 Canada, Inc. is an investment holding Canadian company founded in 2017. The private company is based in Montréal, Canada. | Director/Board Member | - | - |
Career history of David W. Goodman
Former positions of David W. Goodman
Companies | Position | Start | End |
---|---|---|---|
Pendopharm, Inc.
Pendopharm, Inc. Pharmaceuticals: MajorHealth Technology Pendopharm, Inc. is engaged in licensing, partnering, developing and marketing prescription medicines. Its products include Lax-A, helixia, Nasacort and hemovel. The company was founded in 2010 and is headquartered in Montréal, Canada. | President | - | - |
Corporate Secretary | - | - | |
Uman Pharma, Inc.
Uman Pharma, Inc. Pharmaceuticals: GenericHealth Technology Uman Pharma, Inc. develops, manufactures, and markets generic injectable pharmaceutical products. The company was founded in December 20, 2007 and is headquartered in Montreal, Canada. | Director/Board Member | - | - |
Sublimity Therapeutics Ltd.
Sublimity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Sublimity Therapeutics Ltd. develops and manufactures pharmaceutical products. It engages in the development of gastrointestinal and immunological therapeutics. The firm’s lead product, CyCol, harnesses the powerful efficacy of the known immunosuppressive drug, cyclosporine in a safer format by targeting drug release towards the site of diseased tissue in the colon of patients with ulcerative colitis. Its other products include CyCron, AlloCol, CyLow, oral vaccines and oral peptides. The company was founded by Ivan Coulter in 2003 and is headquartered in Dublin, Ireland. | Director/Board Member | - | - |
Training of David W. Goodman
McGill University | Undergraduate Degree |
University of Virginia | Doctorate Degree |
Statistics
International
Canada | 7 |
United States | 3 |
Ireland | 2 |
Operational
Director/Board Member | 5 |
President | 2 |
Chief Executive Officer | 1 |
Sectoral
Health Technology | 6 |
Consumer Services | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 7 |
---|---|
Pharmascience, Inc.
Pharmascience, Inc. Pharmaceuticals: MajorHealth Technology Pharmascience, Inc. manufactures and distributes generic and drug products. It offers liquids, tablets, capsules, suppositories, powders, and ophthalmic. The company was founded by Morris Goodman and Ted S. Wise in 1983 and is headquartered in Montr?al, Canada. | Health Technology |
Sublimity Therapeutics Ltd.
Sublimity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Sublimity Therapeutics Ltd. develops and manufactures pharmaceutical products. It engages in the development of gastrointestinal and immunological therapeutics. The firm’s lead product, CyCol, harnesses the powerful efficacy of the known immunosuppressive drug, cyclosporine in a safer format by targeting drug release towards the site of diseased tissue in the colon of patients with ulcerative colitis. Its other products include CyCron, AlloCol, CyLow, oral vaccines and oral peptides. The company was founded by Ivan Coulter in 2003 and is headquartered in Dublin, Ireland. | Health Technology |
Bionpharma, Inc.
Bionpharma, Inc. Pharmaceuticals: MajorHealth Technology Bionpharma, Inc. provides various specialty pharmaceuticals. It offers Rx generic ANDA and OTC products. The company was founded on Noveber 1, 2014 and is headquartered in Princeton, NJ. | Health Technology |
Pendopharm, Inc.
Pendopharm, Inc. Pharmaceuticals: MajorHealth Technology Pendopharm, Inc. is engaged in licensing, partnering, developing and marketing prescription medicines. Its products include Lax-A, helixia, Nasacort and hemovel. The company was founded in 2010 and is headquartered in Montréal, Canada. | Health Technology |
Centraide of Greater Montreal
Centraide of Greater Montreal Miscellaneous Commercial ServicesCommercial Services Centraide of Greater Montreal supports community agencies in the neighbourhoods. It has four areas of action: supporting youth, providing basic needs, helping the socially isolated and bringing communities together. The company was founded in 1966 and is headquartered in Montr?al, Canada. | Commercial Services |
Uman Pharma, Inc.
Uman Pharma, Inc. Pharmaceuticals: GenericHealth Technology Uman Pharma, Inc. develops, manufactures, and markets generic injectable pharmaceutical products. The company was founded in December 20, 2007 and is headquartered in Montreal, Canada. | Health Technology |
10379085 Canada, Inc.
10379085 Canada, Inc. Financial ConglomeratesFinance 10379085 Canada, Inc. is an investment holding Canadian company founded in 2017. The private company is based in Montréal, Canada. | Finance |
- Stock Market
- Insiders
- David W. Goodman
- Experience